According to new research conducted by the Medical University of Vienna, one in two women who have lobular breast cancer can preserve their breasts if they undergo chemotherapy before a breast operation.
Leader of the study, Prof. Dr. Florian Fitzat, said that until now it had been thought that neoadjuvant chemotherapy was pointless in cases of lobular breast cancer as it hardly showed any benefits at all and the cancer responded poorly. However, no one had yet thought about its effects on the preservation rate of the breast The study has revealed that one in two women would be able to keep her breast with the help of chemo prior to surgery.
The treatment focuses on considerably reducing the size of the cancer so the breast can be preserved after surgical excision in at least 48 percent of the cases.
Image: Shutterstock
